Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Protzer, U; Böhm, F; Longerich, T; Seebach, J; Heidary Navid, M; Friemel, J; Marques-Maggio, E; Bawohl, M; Heikenwalder, M; Schirmacher, P; Dutkowski, P; Clavien, PA; Schemmer, P; Schnitzler, P; Gotthardt, D; Müllhaupt, B; Weber, A.
Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation.
Mod Pathol. 2015; 28(4):523-532 Doi: 10.1038/modpathol.2014.147 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Schemmer Peter
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: We aimed to determine the rate of hepatitis E virus (HEV) infection, a recently increasingly recognized disease in the Western world, in liver transplant patients by direct molecular testing of liver tissue. A RT-PCR assay was designed for detecting the HEV open reading frame (ORF) 2/3 gene region in formalin-fixed, paraffin-embedded tissues, and applied to all liver biopsies (n=683) taken 4 weeks or later from all patients (n=282) after liver transplantation of two large academic centers. HEV-RNA was detected in ten biopsies from four different patients (rate: 1%). Histology in early HEV infection was variable including cases with only few hepatocellular apoptoses, no or only minute inflammation. Hepatitis lasted for at least 6 months in 3/4 patients. Serologic testing for HEV-RNA in a subcohort (159 patients) was positive in five patients (rate: 3%), resulting in an overall HEV detection rate of 3% (8/282). In case both liver tissue and sera of a patient were available from the same time period, all cases tested positive in one material were also tested positive in the other material, respectively. All patients had de novo autochthonous infection with HEV genotype 3. Our data confirm that HEV infection is a relevant cause of liver injury after liver transplantation. Molecular testing for HEV in routinely processed transplant liver biopsies is powerful for evaluating patients with elevated transaminases of unknown origin. Histology of HEV infection under immunosuppression in the early phase is distinct from HEV infection in immunocompetent individuals.
Find related publications in this database (using NLM MeSH Indexing): Adult -; Female -; Hepatitis E - diagnosis; Hepatitis E virus - isolation & purification; Humans -; Liver - pathology; Liver - surgery; Liver - virology; Liver Transplantation -; Male -; Middle Aged -